2376 - 2400 of 8112 Results
Title
Year
-
OPENTitle: Association between cigarette smoking and Parkinson’s disease: a neuroimaging studyJournal Name: Therapeutic Advances in Neurological DisordersPublisher: SAGE PublicationsVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/17562864221092566Best OA location URL: https://doi.org/10.1177/17562864221092566Citation Count: 25
-
OPENTitle: Association of vitamin K with cognitive decline and neuropathology in community‐dwelling older personsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12255Best OA location URL: https://doi.org/10.1002/trc2.12255Citation Count: 36
-
OPENTitle: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer’s Disease and Related ResearchJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #: 1Start Page: 1End Page: 10Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14283/jpad.2022.7Best OA location URL: https://link.springer.com/content/pdf/10.14283/jpad.2022.7.pdfCitation Count: 1
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 26
-
RESTRICTEDTitle: Characterization of Axon Guidance Phenotypes in Wnt/PCP Mutant MiceJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 277End Page: 286Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-2035-9_17Citation Count: 3
-
RESTRICTEDTitle: Clinical neurophysiology of Parkinson’s disease and parkinsonismJournal Name: Clinical Neurophysiology PracticePublisher: Elsevier BVVol: 7Issue #:Start Page: 201End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cnp.2022.06.002Best OA location URL: https://doi.org/10.1016/j.cnp.2022.06.002Citation Count: 33
-
OPENTitle: Concurrent validity of Zeno instrumented walkway and video-based gait features in adults with Parkinson’s diseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 22
-
RESTRICTEDTitle: Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 235End Page: 279Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.09.006Citation Count: 0
-
OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 0
-
OPENTitle: Define and visualize pathological architectures of human tissues from spatially resolved transcriptomics using deep learningJournal Name: Computational and Structural Biotechnology JournalPublisher: Elsevier BVVol: 20Issue #:Start Page: 4600End Page: 4617Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.csbj.2022.08.029Best OA location URL: https://doi.org/10.1016/j.csbj.2022.08.029Citation Count: 37
-
RESTRICTEDTitle: Depression and Parkinson's disease: a Chicken-Egg storyJournal Name: AIMS NeurosciencePublisher: American Institute of Mathematical Sciences (AIMS)Vol: 9Issue #: 4Start Page: 479End Page: 490Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3934/neuroscience.2022027Best OA location URL: https://doi.org/10.3934/neuroscience.2022027Citation Count: 2
-
OPENTitle: Detection of emerging neurodegeneration using Bayesian linear mixed-effect modelingJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103144End Page: 103144Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103144Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103144Citation Count: 4
-
OPENTitle: Distinct atrophy of septal nuclei in Parkinson’s diseaseJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100171End Page: 100171Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100171Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100171Citation Count: 1
-
OPENTitle: DNA Sequence Analysis for Brain Disorder Using Deep Learning and Secure StorageJournal Name: Computers, Materials & ContinuaPublisher: Tech Science PressVol: 71Issue #: 3Start Page: 5949End Page: 5962Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.32604/cmc.2022.022028Best OA location URL: https://www.techscience.com/cmc/v71n3/46465/pdfCitation Count: 5
- Drug News2022RESTRICTEDTitle: Drug NewsJournal Name: NursingPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 52Issue #: 1Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nurse.0000803500.30920.0cCitation Count: 0
-
OPENTitle: Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic TherapyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 15End Page: 23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000525664Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671814Citation Count: 3
-
RESTRICTEDTitle: Environmental neurotoxicants and inflammasome activation in Parkinson’s disease – A focus on the gut-brain axisJournal Name: The International Journal of Biochemistry & Cell BiologyPublisher: Elsevier BVVol: 142Issue #:Start Page: 106113End Page: 106113Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biocel.2021.106113Citation Count: 8
-
OPENTitle: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoringJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100145End Page: 100145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100145Citation Count: 8
-
RESTRICTEDTitle: Evaluation of the Dementia Apraxia Test in Parkinson’s Disease PatientsJournal Name: Dementia and Geriatric Cognitive DisordersPublisher: S. Karger AGVol: 51Issue #: 3Start Page: 271End Page: 278Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000525618Citation Count: 1
-
RESTRICTEDTitle: Exploration of Protein Aggregations in Parkinson’s Disease Through Computational Approaches and Big Data AnalyticsJournal Name: Methods in Molecular BiologyPublisher: Springer USVol:Issue #:Start Page: 449End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-0716-1546-1_19Citation Count: 2
-
RESTRICTEDTitle: Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapyJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 175Issue #:Start Page: 105980End Page: 105980Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.phrs.2021.105980Best OA location URL: http://manuscript.elsevier.com/S1043661821005648/pdf/S1043661821005648.pdfCitation Count: 12
-
OPENTitle: GaitForeMer: Self-supervised Pre-training of Transformers via Human Motion Forecasting for Few-Shot Gait Impairment Severity EstimationJournal Name: Lecture Notes in Computer SciencePublisher: Springer Nature SwitzerlandVol:Issue #:Start Page: 130End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/978-3-031-16452-1_13Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635991Citation Count: 14
-
OPENTitle: Gastric acid suppressants and cognitive decline in people with or without cognitive impairmentJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12243Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/trc2.12243Citation Count: 11
-
RESTRICTEDTitle: Hippocampal Functional Connectivity in Parkinson’s DiseaseJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 22Issue #: 1Start Page: 29End Page: 33Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1159/000526377Citation Count: 6